← Eichor
Study identifier: NCT06741059 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea

Condition: Dysmenorrhea  ·  Sponsor: Osmaniye Korkut Ata University

PhaseNA
Planned participants93
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Menstrual Symptoms in Primary Dysmenorrhea This study aims to investigate the effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in managing pain and alleviating menstrual symptoms in individuals with primary dysmenorrhea. Primary dysmenorrhea is characterized by severe menstrual pain and accompanying symptoms that negatively impact the quality of life and daily functioning. TENS, a non-invasive and drug-free method, is applied to relieve pain by stimulating nerves through electrical impulses. This research evaluates the impact of TENS on both the intensity of menstrual pain and associated symptoms, offering insights into its potential as an alternative or complementary therapeutic approach.

This description comes directly from the study's public registry record.

Talk to the study team

Esra U Unal, Doctor  ·  +905342878405  ·  esraunal2428@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Esra ÜnalOsmaniye, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06741059